181 related articles for article (PubMed ID: 29877104)
1. Carvacrol activity & morphological changes in Mycobacterium tuberculosis.
Nakamura de Vasconcelos SS; Caleffi-Ferracioli KR; Hegeto LA; Baldin VP; Nakamura CV; Stefanello TF; Freitas Gauze G; Yamazaki DA; Scodro RB; Siqueira VL; Cardoso RF
Future Microbiol; 2018 Jun; 13():877-888. PubMed ID: 29877104
[TBL] [Abstract][Full Text] [Related]
2. In vitro combinatory activity of piperine and anti-tuberculosis drugs in Mycobacterium tuberculosis.
Hegeto LA; Caleffi-Ferracioli KR; Nakamura-Vasconcelos SS; Almeida AL; Baldin VP; Nakamura CV; Siqueira VLD; Scodro RBL; Cardoso RF
Tuberculosis (Edinb); 2018 Jul; 111():35-40. PubMed ID: 30029912
[TBL] [Abstract][Full Text] [Related]
3. Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis.
Maltempe FG; Caleffi-Ferracioli KR; do Amaral RCR; de Oliveira Demitto F; Siqueira VLD; de Lima Scodro RB; Hirata MH; Pavan FR; Cardoso RF
Tuberculosis (Edinb); 2017 May; 104():24-29. PubMed ID: 28454646
[TBL] [Abstract][Full Text] [Related]
4. Morphological changes and differentially expressed efflux pump genes in Mycobacterium tuberculosis exposed to a rifampicin and verapamil combination.
Caleffi-Ferracioli KR; Amaral RC; Demitto FO; Maltempe FG; Canezin PH; Scodro RB; Nakamura CV; Leite CQ; Siqueira VL; Cardoso RF
Tuberculosis (Edinb); 2016 Mar; 97():65-72. PubMed ID: 26980498
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Evaluation of Novel Hybrid Efflux Pump Inhibitors for Use against Mycobacterium tuberculosis.
Kumar M; Singh K; Naran K; Hamzabegovic F; Hoft DF; Warner DF; Ruminski P; Abate G; Chibale K
ACS Infect Dis; 2016 Oct; 2(10):714-725. PubMed ID: 27737555
[TBL] [Abstract][Full Text] [Related]
6. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD
Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742
[TBL] [Abstract][Full Text] [Related]
7. Activity of (-)-Camphene Derivatives Against Mycobacterium tuberculosis in Acidic pH.
de Carvalho HC; Ieque AL; Valverde TL; Baldin VP; Meneguello JE; Campanerut-Sá PAZ; Vandresen F; Ghiraldi Lopes LD; Passos Souza MR; Santos NCS; Dias Siqueira VL; Caleffi-Ferracioli KR; Lima Scodro RB; Cardoso RF
Med Chem; 2021; 17(5):485-492. PubMed ID: 31702530
[TBL] [Abstract][Full Text] [Related]
8. Modulatory effects of verapamil in rifampicin activity against Mycobacterium tuberculosis.
Caleffi-Ferracioli KR; Cardoso RF; de Souza JV; Murase LS; Canezin PH; Scodro RB; Ld Siqueira V; Pavan FR
Future Microbiol; 2019 Feb; 14():185-194. PubMed ID: 30648892
[TBL] [Abstract][Full Text] [Related]
9. Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis.
Sharma S; Kumar M; Sharma S; Nargotra A; Koul S; Khan IA
J Antimicrob Chemother; 2010 Aug; 65(8):1694-701. PubMed ID: 20525733
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-Mycobacterium tuberculosis activity of imide-β-carboline and carbomethoxy-β-carboline derivatives.
Lopes-Ortiz MA; Panice MR; Borges de Melo E; Ataide Martins JP; Baldin VP; Agostinho Pires CT; Caleffi-Ferracioli KR; Dias Siqueira VL; Bertin de Lima Scodro R; Sarragiotto MH; Cardoso RF
Eur J Med Chem; 2020 Feb; 187():111935. PubMed ID: 31816556
[TBL] [Abstract][Full Text] [Related]
11. Anti-Mycobacterium tuberculosis activity of antituberculosis drugs and amoxicillin/clavulanate combination.
Pagliotto AD; Caleffi-Ferracioli KR; Lopes MA; Baldin VP; Leite CQ; Pavan FR; Scodro RB; Siqueira VL; Cardoso RF
J Microbiol Immunol Infect; 2016 Dec; 49(6):980-983. PubMed ID: 26454420
[TBL] [Abstract][Full Text] [Related]
12. Potential of Casiopeínas® Copper Complexes and Antituberculosis Drug Combination against Mycobacterium tuberculosis.
Barbosa AR; Caleffi-Ferracioli KR; Leite CQ; García-Ramos JC; Toledano-Magaña Y; Ruiz-Azuara L; Siqueira VL; Pavan FR; Cardoso RF
Chemotherapy; 2016; 61(5):249-55. PubMed ID: 26950478
[TBL] [Abstract][Full Text] [Related]
13. Ofloxacin resistance in Mycobacterium tuberculosis is associated with efflux pump activity independent of resistance pattern and genotype.
Sun Z; Xu Y; Sun Y; Liu Y; Zhang X; Huang H; Li C
Microb Drug Resist; 2014 Dec; 20(6):525-32. PubMed ID: 24940805
[TBL] [Abstract][Full Text] [Related]
14. Proteomic and morphological changes produced by subinhibitory concentration of isoniazid in Mycobacterium tuberculosis.
Campanerut-Sá PA; Ghiraldi-Lopes LD; Meneguello JE; Fiorini A; Evaristo GP; Siqueira VL; Scodro RB; Patussi EV; Donatti L; Souza EM; Cardoso RF
Future Microbiol; 2016 Sep; 11():1123-32. PubMed ID: 27545345
[TBL] [Abstract][Full Text] [Related]
15. Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of
Narang A; Giri A; Gupta S; Garima K; Bose M; Varma-Basil M
Int J Mycobacteriol; 2017; 6(2):177-183. PubMed ID: 28559521
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of nitrate reduction assay, resazurin microtiter assay and microscopic observation drug susceptibility assay for first line antitubercular drug susceptibility testing of clinical isolates of M. tuberculosis.
Dixit P; Singh U; Sharma P; Jain A
J Microbiol Methods; 2012 Jan; 88(1):122-6. PubMed ID: 22133919
[TBL] [Abstract][Full Text] [Related]
17. Rescue of streptomycin activity by piperine in
Calsavara LL; Hegeto LA; Sampiron EG; Costacurta GF; Murase LS; Souza JV; de Almeida AL; de S Santos NC; Siqueira VL; de L Scodro RB; Cardoso RF; Caleffi-Ferracioli KR
Future Microbiol; 2021 Jun; 16():623-633. PubMed ID: 34098743
[No Abstract] [Full Text] [Related]
18. Determination of minimum bactericidal concentration, in single or combination drugs, against
Santos NCS; Scodro RBL; Leal DC; do Prado SM; Micheletti DF; Sampiron EG; Costacurta GF; de Almeida AL; da Silva LA; Ieque AL; Ghiraldi Lopes LD; de Pádua RA; Siqueira VL; Caleffi-Ferracioli KR; Cardoso RF
Future Microbiol; 2020 Jan; 15():107-114. PubMed ID: 32064924
[No Abstract] [Full Text] [Related]
19. The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase.
Mori G; Orena BS; Franch C; Mitchenall LA; Godbole AA; Rodrigues L; Aguilar-Pérez C; Zemanová J; Huszár S; Forbak M; Lane TR; Sabbah M; Deboosere N; Frita R; Vandeputte A; Hoffmann E; Russo R; Connell N; Veilleux C; Jha RK; Kumar P; Freundlich JS; Brodin P; Aínsa JA; Nagaraja V; Maxwell A; Mikušová K; Pasca MR; Ekins S
Tuberculosis (Edinb); 2018 Sep; 112():98-109. PubMed ID: 30205975
[TBL] [Abstract][Full Text] [Related]
20. Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method.
Caleffi-Ferracioli KR; Maltempe FG; Siqueira VL; Cardoso RF
Tuberculosis (Edinb); 2013 Nov; 93(6):660-3. PubMed ID: 24083948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
